DYNAVAX TECH (NASDAQ:DVAX)
1.49
+0.05 (3.47%)
| DYNAVAX TECH (NASDAQ:DVAX) Delayed : | |||||
|---|---|---|---|---|---|
| Previous Close | $1.44 | 52 Week High | $3.35 | ||
| Open | $1.57 | 52 Week Low | $0.50 | ||
| Day High | $1.60 | P/E | 21.29 | ||
| Day Low | $1.45 | EPS | $0.07 | ||
| Volume | 230,232 | ||||
| More DVAX Info: Chart SEC Filings Profile Historical Options | |||||
What is this?Friends, Peers and Foes
| Ticker | # Stories | Ticker | # Stories |
|---|---|---|---|
| NVAX | 5 | VICL | 4 |
| HEB | 4 | SVA | 4 |
| AVII | 4 | GNBT | 3 |
| NVAX | 3 | UAUA | 3 |
| GSK | 3 | HEB | 3 |
| AVII | 3 | BCRX | 3 |
Entities who have mentioned DVAX
- StreetInsider.com Morning Movers | View Related Stories »
- Unusual 11 Mid-Day Movers | View Related Stories »
- Lehman Brothers | View Related Stories »
- Goldman Sachs | View Related Stories »
- Citi | View Related Stories »
- JPMorgan | View Related Stories »
- UBS | View Related Stories »
- Barclays | View Related Stories »
- Dividend | View Related Stories »
- Raymond James | View Related Stories »
- Crude Oil | View Related Stories »
- Ramius Capital | View Related Stories »
- Merriman Curhan Ford | View Related Stories »
- Bear Stearns | View Related Stories »
- Carl Icahn | View Related Stories »
- Nelson Peltz | View Related Stories »
- Trian Fund | View Related Stories »
- Piper Jaffray | View Related Stories »
- Robert W Baird | View Related Stories »
- S3 | View Related Stories »
- Sterne Agee | View Related Stories »
- 13D | View Related Stories »
- Life, Style and Real Estate | View Related Stories »
- Morgan Stanley | View Related Stories »
- After-Hours Movers | View Related Stories »
View All Major News StreetInsider.com Major News for DVAX
- Dynavax Technologies (DVAX) Reports Q3 loss of $0.24
- FDA Removes Clinical Hold for Dynavax's (DVAX) IND HEPLISAV
- Dynavax (DVAX) Higher After Meeting With FDA On Plans To Resume HEPLISAVTM Development
View All ReportsStreetInsider.com Reports on DVAX
- Dynavax Tech (DVAX) Initiates HEPLISAV Phase 3
- Dynavax (DVAX) In Talks With Potential Partners on Hepatitis C Drug
- Dynavax Tech (DVAX) Announces Positive Results from SD-101 in Patients with HCV
- Dynavax Tech. (DVAX) to Sell Up to 15M Shares of Common Stock
- Unusual 11 Mid-Day Movers 12/09: DVAX, FBP, RNWK, VCI Higher; CMRO, MOV, RGEN, CLUB Lower
View All Press ReleasesCompany Press Releases on DVAX
- Dynavax Initiates Large-Scale Phase 3 Trial of HEPLISAV(TM)
- Biotech Market Review for Dynavax Technologies Corp. Issued by StockPreacher
- Dynavax Reports Positive Phase 1b Data for SD-101 in Chronic Hepatitis C Infection
- Dynavax Expands Commercial and Clinical Leadership
- Dynavax Completes Symphony Dynamo Acquisition
StreetInsider Reports on DVAX by Category
View All BlogsBlogs on DVAX
- FDA Calendar Updates: Covidien, Dynavax, Nuvo Research
- Swine Flu Stocks - Just Wait Until Fall
- Dynavax Surge Not Warranted
- Biotech Implosion: Dynavax (DVAX)
- Top Pre-Market Analyst Downgrades (AMP, AAPL, DVAX, FCX, GMT, LNC, PCX, X)
View All FilingsSEC Filings on DVAX
- Form 8-K DYNAVAX TECHNOLOGIES For: Feb 08
- Form 8-K DYNAVAX TECHNOLOGIES For: Jan 26
- Form SC 13D DYNAVAX TECHNOLOGIES Filed by: Symphony Capital Partners LP
- Form S-3 DYNAVAX TECHNOLOGIES
- Form 4 DYNAVAX TECHNOLOGIES For: Dec 30 Filed by: KESSEL MARK
Comments on recent DVAX articles
Comments on DVAX
No comments are currently available.
on Sep 6, 2009
at 12:01 PM Swine flu Did anyone go to www.swineflustocks.com ? I believe it's up for sale for $50,000. I heard it was purchased not to long ago for $10. Talk about a potential rate of return. Do the math.
Article: Swine Flu Stocks Could Be Hot As Fears Grow and Vaccine Production Put In Motion
on Oct 23, 2008
at 09:43 PM dynavax The US is full of stupid short sighted investors with no business investing in anything, let alone speculative companies doing good for the world like DVAX.
Article: Dynavax (DVAX) Slammed As HEPLISAV Looks Like a Bust in Hep B